MACROGENICS INC (19)

Browse by Contract Category

Contracts

Amendment No (Filed With SEC on November 3, 2022)
Amendment No. 2 to the Global Collaboration and License Agreement by and between the Company and Incyte Corporation, dated April 7, 2022 (Filed With SEC on August 8, 2022)
Employment Agreement between the Company and Thomas Spitznagel Ph.D (Filed With SEC on May 3, 2022)
Stock Purchase Agreement by and between the Company and Zai Lab Limited, dated June 14, 2021 (Filed With SEC on July 29, 2021)
Fourth Amendment to the Option for a License Agreement by and between the Company and Les Laboratoires Servier and Institut de Recherches Servier, dated June 6, 2019 (Filed With SEC on July 31, 2019)
Collaboration and License Agreement by and between the Company and Zai Lab US LLC, dated June 15, 2021 (Filed With SEC on July 29, 2021)
Amendment No. 1 to Sales Agreement, dated April 29, 2021, between MacroGenics, Inc. and Cowen and Company, LLC (Filed With SEC on April 29, 2021)
Employment Agreement between the Company and Stephen Eck, M.D (Filed With SEC on April 29, 2021)
Commercial Supply Agreement by and between Incyte Corporation and the Company, dated (Filed With SEC on February 25, 2021)
Product Commercialization Agreement by and between the Company and Eversana Life Science Service (Filed With SEC on February 25, 2021)
Commercial Supply Agreement by and between (Filed With SEC on February 25, 2021)
Description of Common Stock (Filed With SEC on February 25, 2021)
Amendment No. 1 to Sales Agreement, dated June 19, 2020, between MacroGenics, Inc. and Cowen and Company, LLC (Filed With SEC on June 19, 2020)
Amendment No.1 to Employment Agreement between the Company and Scott Koenig, M.D., Ph.D (Filed With SEC on May 5, 2020)
Description of Common Stock (Filed With SEC on February 25, 2020)
Third Amendment to the Option for a License Agreement by and between the Company and Les Laboratoires Servier and Institut de Recherches Servier, dated June 6, 2019 (Filed With SEC on July 31, 2019)
Second Amendment to Option for a License Agreement by and between the Company and Les Laboratoires Servier and Institut de Recherches Servier, dated March 1, 2018 (Filed With SEC on February 26, 2019)
First Amendment to Option for a License Agreement by and between the Company and Les Laboratoires Servier and Institut de Recherches Servier, dated June 14, 2017 (Filed With SEC on February 26, 2019)
Underwriting Agreement, dated February 12, 2019, by and among MacroGenics, Inc. and SVB Leerink LLC and Evercore Group L.L.C., as representatives of the Underwriters (Filed With SEC on February 15, 2019)